Cargando…

Exploring the effect of ritonavir and TMC-310911 on SARS-CoV-2 and SARS-CoV main proteases: potential from a molecular perspective

AIM: As coronavirus (CoV) disease 2019-associated pneumonia spreads globally, there has been an urgent need to combat the spread and develop vaccines. MATERIALS & METHODS: We used an integrated computational algorithm to explore the binding mechanism of TMC-310911/ritonavir (RVT) with SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soremekun, Opeyemi S, Omolabi, Kehinde F, Adewumi, Adeniyi T, Soliman, Mahmoud ES
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Science Ltd 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7651988/ https://www.ncbi.nlm.nih.gov/pubmed/33432269 http://dx.doi.org/10.2144/fsoa-2020-0079

Ejemplares similares

Identification and classification of differentially expressed genes reveal potential molecular signature associated with SARS-CoV-2 infection in lung adenocarcinomal cells
por: Soremekun, Opeyemi S., et al.
Publicado: (2020)

Leaving no stone unturned: Allosteric targeting of SARS-CoV-2 spike protein at putative druggable sites disrupts human angiotensin-converting enzyme interactions at the receptor binding domain
por: Olotu, Fisayo A., et al.
Publicado: (2020)

Piece of the puzzle: Remdesivir disassembles the multimeric SARS-CoV-2 RNA-dependent RNA polymerase complex
por: Olotu, Fisayo A., et al.
Publicado: (2021)

Activation and maturation of SARS-CoV main protease
por: Xia, Bin, et al.
Publicado: (2011)

Identification of promising high-affinity inhibitors of SARS-CoV-2 main protease from African Natural Products Databases by Virtual Screening
por: DIABATE, Oudou, et al.
Publicado: (2023)

Non-conventional interactions of N3 inhibitor with the main protease of SARS-CoV and SARS-CoV-2
por: García-Gutiérrez, Ponciano, et al.
Publicado: (2021)

The SARS-CoV-2 main protease as drug target
por: Ullrich, Sven, et al.
Publicado: (2020)

Topological analysis of SARS CoV-2 main protease
por: Estrada, Ernesto
Publicado: (2020)

Potential SARS-CoV-2 main protease inhibitors
por: Banerjee, Riddhidev, et al.
Publicado: (2021)

Developing inhibitors of the SARS-CoV-2 main protease
por: Seitz, Christian, et al.
Publicado: (2022)

Allosteric Hotspots in the Main Protease of SARS-CoV-2
por: Strömich, Léonie, et al.
Publicado: (2022)

Allosteric inhibitors of the main protease of SARS-CoV-2
por: Samrat, Subodh Kumar, et al.
Publicado: (2022)

Suggesting Ritonavir against COVID-19/SARS-CoV-2
por: Choudhury, Shuvasish, et al.
Publicado: (2020)

SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapy
por: Edelstein, Gregory E., et al.
Publicado: (2023)

Enhancement of SARS-CoV Infection by Proteases
por: Matsuyama, Shutoku, et al.
Publicado: (2006)

Protein structural heterogeneity: A hypothesis for the basis of proteolytic recognition by the main protease of SARS-CoV and SARS-CoV-2
por: Behnam, Mira A.M.
Publicado: (2021)

In silico exploration of binding potentials of anti SARS-CoV-1 phytochemicals against main protease of SARS-CoV-2
por: Al-Sehemi, Abdullah G., et al.
Publicado: (2022)

Structure and inhibition of SARS-CoV-1 and SARS-CoV-2 main proteases by oral antiviral compound AG7404
por: Fàbrega-Ferrer, Montserrat, et al.
Publicado: (2022)

Biochemical screening for SARS-CoV-2 main protease inhibitors
por: Coelho, Camila, et al.
Publicado: (2020)

Structure of SARS-CoV-2 main protease in the apo state
por: Zhou, Xuelan, et al.
Publicado: (2020)

Correlation between dissociation and catalysis of SARS-CoV main protease
por: Lin, Pei-Ying, et al.
Publicado: (2008)

Copper(II) Inhibition of the SARS-CoV-2 Main Protease
por: Garza-López, Roberto A., et al.
Publicado: (2020)

Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors
por: Huff, Sarah, et al.
Publicado: (2021)

Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease
por: Katagishi, Daiki, et al.
Publicado: (2023)

Optimization of the expression of the main protease from SARS-CoV-2
por: Rong, Yi, et al.
Publicado: (2023)

Potent and biostable inhibitors of the main protease of SARS-CoV-2
por: Tsuji, Kohei, et al.
Publicado: (2022)

Insights into the structural properties of SARS-CoV-2 main protease
por: Akbayrak, Ibrahim Yagiz, et al.
Publicado: (2022)

Dynamics of the SARS-CoV-2 main protease binding site
por: Harith, Advaith S., et al.
Publicado: (2023)

Effect of chitooligosaccharide on the inhibition of SARS-CoV-2 main protease
por: Wang, Qian, et al.
Publicado: (2023)

Characterization of host substrates of SARS-CoV-2 main protease
por: Melano, Ivonne, et al.
Publicado: (2023)

SARS-CoV and SARS-CoV-2 main protease residue interaction networks change when bound to inhibitor N3
por: Griffin, Jeddidiah W.D.
Publicado: (2020)

Rebound of SARS-CoV-2 Infection after Nirmatrelvir–Ritonavir Treatment
por: Charness, Michael E., et al.
Publicado: (2022)

Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir
por: Bolcato, Giovanni, et al.
Publicado: (2020)

Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
por: Douangamath, Alice, et al.
Publicado: (2020)

Computational Prediction of Potential Inhibitors of the Main Protease of SARS-CoV-2
por: Abel, Renata, et al.
Publicado: (2020)

Supercomputer simulation of the covalent inhibition of the main protease of SARS-CoV-2
por: Nemukhin, A. V., et al.
Publicado: (2022)

A new inactive conformation of SARS‐CoV‐2 main protease
por: Fornasier, Emanuele, et al.
Publicado: (2022)

A cyclic peptide inhibitor of the SARS-CoV-2 main protease
por: Kreutzer, Adam G., et al.
Publicado: (2021)

Antiviral cyclic peptides targeting the main protease of SARS-CoV-2
por: Johansen-Leete, Jason, et al.
Publicado: (2022)

Cotton flower metabolites inhibit SARS‐CoV‐2 main protease
por: Zhang, Yufang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tsane7au0ahpun0e4db5ugd8mm